Susquehanna International Group
FLGT icon

Susquehanna International Group’s Fulgent Genetics FLGT Stock Holding History

Susquehanna International Group’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$605K Buy
38,078
+27,310
+254% +$593K ﹤0.01% 9169
2025
Q4 		$283K Sell
10,768
-9,531
-47% -$247K ﹤0.01% 10082
2025
Q3 		$459K Sell
20,299
-149,666
-88% -$3.08M ﹤0.01% 9164
2025
Q2 		$3.38M Buy
169,965
+108,227
+175% +$2.11M ﹤0.01% 4727
2025
Q1 		$1.04M Buy
61,738
+34,496
+127% +$588K ﹤0.01% 7154
2024
Q4 		$503K Buy
27,242
+12,675
+87% +$247K ﹤0.01% 8645
2024
Q3 		$317K Buy
+14,567
New +$326K ﹤0.01% 9485
2024
Q2 		– Sell
-67,686
Closed -$1.41M – 12372
2024
Q1 		$1.47M Buy
67,686
+52,864
+357% +$1.31M ﹤0.01% 6055
2023
Q4 		$429K Buy
+14,822
New +$397K ﹤0.01% 9046
2023
Q3 		– Sell
-53,975
Closed -$1.84M – 12288
2023
Q2 		$2M Sell
53,975
-35,503
-40% -$1.24M ﹤0.01% 5167
2023
Q1 		$2.79M Buy
89,478
+2,059
+2% +$66.3K ﹤0.01% 4459
2022
Q4 		$2.6M Sell
87,419
-31,630
-27% -$1.13M ﹤0.01% 4242
2022
Q3 		$4.54M Buy
119,049
+62,463
+110% +$3.13M ﹤0.01% 3319
2022
Q2 		$3.09M Buy
56,586
+6,990
+14% +$384K ﹤0.01% 4017
2022
Q1 		$3.1M Sell
49,596
-17,715
-26% -$1.17M ﹤0.01% 4565
2021
Q4 		$6.77M Sell
67,311
-46,951
-41% -$4.13M ﹤0.01% 3254
2021
Q3 		$10.3M Sell
114,262
-50,357
-31% -$4.58M ﹤0.01% 2823
2021
Q2 		$15.2M Buy
164,619
+20,281
+14% +$1.62M ﹤0.01% 2361
2021
Q1 		$13.9M Buy
144,338
+43,484
+43% +$4.49M ﹤0.01% 2323
2020
Q4 		$5.25M Buy
+100,854
New +$4.21M ﹤0.01% 3342
2020
Q2 		– Sell
-98,923
Closed -$1.06M – 10344
2020
Q1 		$1.06M Buy
98,923
+45,800
+86% +$638K ﹤0.01% 5265
2019
Q4 		$685K Buy
+53,123
New +$631K ﹤0.01% 6301
2018
Q4 		– Sell
-25,298
Closed -$99K – 9229
2018
Q3 		$99K Buy
25,298
+5,570
+28% +$23.8K ﹤0.01% 8606
2018
Q2 		$82K Buy
19,728
+8,749
+80% +$34.7K ﹤0.01% 9121
2018
Q1 		$44K Buy
+10,979
New +$48.3K ﹤0.01% 8988

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Susquehanna International Group's FLGT Position: Q1 2026 in Review

Susquehanna International Group increased its Fulgent Genetics (FLGT) stake by 254% in Q1 2026, buying an estimated $593K and bringing the position to 38,078 shares worth $605K. The position accounts for ﹤0.01% of the portfolio, ranked #9169.

Susquehanna International Group first reported a position in FLGT in Q1 2018 and has held it in 25 quarters since. The position peaked at $15.2M in Q2 2021. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • Susquehanna International Group held 38,078 shares of Fulgent Genetics worth $605K as of Q1 2026.
  • Susquehanna International Group bought 27,310 Fulgent Genetics shares in Q1 2026, an estimated $593K.
  • Fulgent Genetics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #9169 holding.
  • Susquehanna International Group first reported a position in Fulgent Genetics in Q1 2018 and has held it in 25 quarters since.
  • Susquehanna International Group's Fulgent Genetics position peaked at $15.2M in Q2 2021.
  • 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.